FBR Announces Addition to Healthcare Team

Andrew Scott Berens, MD, to Cover Biotechnology Sector for FBR's Research Team

| Source: FBR & Co.

ARLINGTON, Va., May 14, 2014 (GLOBE NEWSWIRE) -- FBR & Co. (Nasdaq:FBRC) (FBR), a leading investment bank serving the middle market, announced today that Andrew Scott Berens, MD, has joined the firm as Senior Vice President, Senior Analyst in FBR's Research group. Berens will cover companies in the biotech sector from FBR's New York office.

"With experience both as a practicing physician and a respected Wall Street analyst, Andy brings tremendous depth of knowledge and critical insights to the investment process for our clients evaluating opportunities in the healthcare space," said David M. Hilal, CFA, Director of Research for FBR. "The dynamic healthcare market, coupled with its increasingly significant role in our economy, make it an ideal sector for us to focus our resources so we can deliver unique, value-added research through our proprietary framework - The Debate TM. We look forward to Andy's contributions to our platform."  

Dr. Berens began his professional career as a practicing physician in New Orleans, LA where he spent more than ten years in Emergency Medicine.  Since then, he has spent nearly ten years covering the healthcare sector on Wall Street, having held positions at Citi and Merrill Lynch/Bank of America.  Most recently he served as Senior Equity Research Analyst and Healthcare Sector head for Bloomberg Industries. He holds a B.A. from Tulane University, an M.D. from Emory University School of Medicine, and M.B.A.'s from the London Business School and Columbia Business School.  

Dr. Berens joins FBR's Healthcare Research team which includes: Steve Halper, Managing Director; Bill Tanner, Managing Director; Andrea Alfonso and Matt Lillis, Associate Vice Presidents, and Cal Sternick, Associate.  The team currently covers approximately forty stocks with a focus on Biopharma, Healthcare Facilities, Healthcare IT, Managed Care, and Pharmaceutical Services. "We have a strong base upon which to build, and are actively looking to further expand our Healthcare franchise," said Hilal. 

FBR & Co. (Nasdaq:FBRC) provides investment banking, merger and acquisition advisory, institutional brokerage, and research services through its subsidiary FBR Capital Markets & Co. FBR focuses capital and financial expertise on the following industry sectors: consumer; diversified industrials; energy & natural resources; financial institutions; healthcare; insurance; real estate; and technology, media & telecom. FBR is headquartered in the Washington, D.C. metropolitan area with offices throughout the United States. For more information, please visit www.fbr.com.

Investors: Bradley J. Wright at 703.312.9678
or bwright@fbr.com
Media: Shannon Hawkins at 703.469.1190
or shawkins@fbr.com